BioCryst Pharmaceuticals Inc (BCRX)
7.345
-1.08
(-12.87%)
USD |
NASDAQ |
Nov 04, 16:00
7.31
-0.04
(-0.48%)
After-Hours: 20:00
BioCryst Pharmaceuticals EBIT Margin (TTM)
EBIT Margin (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBIT Margin (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| Date | Value |
|---|---|
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
| March 31, 2012 | -- |
EBIT Margin Definition
An EBIT Margin is the operating earnings over operating sales. This margin allows investors to understand true business costs of running a company, because parts of a company's property, plant, and equipment will eventually need to be replaced as they get used, broken down, decayed, etc.